| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Brandt Peter C. | Director | C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK | /s/ Jason Minio, Attorney-in-Fact | 07 May 2025 | 0001434099 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INAB | Common Stock | Options Exercise | $15,115 | +81,967 | +16% | $0.1844 | 599,571 | 30 Apr 2025 | Direct | |
| transaction | INAB | Common Stock | Options Exercise | $15,115 | +81,967 | +14% | $0.1844 | 681,538 | 30 Apr 2025 | Direct | |
| holding | INAB | Common Stock | 105,290 | 27 Apr 2025 | See footnote | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INAB | Series A Warrants (right to buy) | Disposed to Issuer | -81,967 | -100% | 0 | 27 Apr 2025 | Common Stock | 81,967 | $0.4500 | Direct | F2, F3, F4 | ||
| transaction | INAB | Series A Warrants (right to buy) | Award | +81,967 | 81,967 | 27 Apr 2025 | Common Stock | 81,967 | $0.1844 | Direct | F2, F3 | |||
| transaction | INAB | Series A Warrants (right to buy) | Options Exercise | $0 | -81,967 | -100% | $0.000000 | 0 | 30 Apr 2025 | Common Stock | 81,967 | $0.1844 | Direct | F3 |
| transaction | INAB | Series B Warrants (right to buy) | Disposed to Issuer | -81,967 | -100% | 0 | 27 Apr 2025 | Common Stock | 81,967 | $1.50 | Direct | F3, F4, F5 | ||
| transaction | INAB | Series B Warrants (right to buy) | Award | +81,967 | 81,967 | 27 Apr 2025 | Common Stock | 81,967 | $0.1844 | Direct | F3, F5 | |||
| transaction | INAB | Series B Warrants (right to buy) | Options Exercise | $0 | -81,967 | -100% | $0.000000 | 0 | 30 Apr 2025 | Common Stock | 81,967 | $0.1844 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT. |
| F2 | The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. |
| F3 | Fully vested and exercisable. |
| F4 | The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock. |
| F5 | The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. |